Researchers are examining Manfredokimab AK120, a novel interleukin 17A (IL-17A) antagonist, for a treatment option for those diagnosed with ulcerative colitis. Preliminary data indicate that this therapy https://socialmediainuk.com/story27213370/manfredokimab-ak120-a-promising-possibility-for-uc